Abstract
No public abstract is available from the verified source records.
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureJoy Y. Zhang
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Research Leaders: Leading countries/territories in health sciences
2026
Gene and cell therapies in China: booming landscape under dual-track regulation
10.1186/s13045-022-01354-9 · 2022
Exclusive: Death of girl in Chinese gene-editing trial was never made public
2026
Once Again, Child Dies in Gene-Editing Trial in China, Rekindling Debate on Transparency and Safety
2026
Is Chinese bioethics ready to move forward from the CRISPR baby scandal?
2023
Unresolved referenced work
2012
He Jiankui’s unprecedented offense and worrying comeback: how the CRISPR-babies scandal reshaped the legal governance of scientific research in China
10.1080/23299460.2024.2372116 · 2024
China should undertake more risky research to close the Nobel gap
10.1038/d41586-025-03615-2 · 2025
Regulation on the Administration of Clinical Research and Clinical Translational Application of New Biomedical Technologies
2025
No additional external references are available.